Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
Dose Ranging Study of Dialysate Containing Soluble Iron to Treat Subjects With End Stage Renal Disease (ESRD) Receiving Chronic Hemodialysis
This study has been completed.
Study NCT00548249 Information provided by Rockwell Medical Technologies, Inc.
First Received on October 19, 2007. Last Updated on February 7, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Chronic Kidney Disease
Additional conditions recognized in this trial
Kidney Failure, Chronic
Renal Insufficiency, Chronic
More general conditions related to this trial
Interventions listed in this trial
Standard Bicarbonate Solution
Soluble Ferric Pyrophosphate
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Physiological Effects of Drugs
Sponsors listed in this trial
Rockwell Medical Technologies, Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers